Tempus HRD-RNA is an AI-driven, 1,660-gene logistic regression model designed to identify patients likely to respond to ...

Tempus AI Inc. TEM shares are up on Thursday as Mizuho initiated coverage on the health care-focused artificial intelligence ...

Tempus AI, Inc. (NASDAQ:TEM) shares are climbing today after the company unveiled a new AI-powered cancer diagnostic ...

Tempus AI TEM rose on Wednesday after the company unveiled its new HRD-RNA algorithm, an AI-driven tool designed to improve ...

TEM rolls out new AI tools across oncology, cardiology and mental health, accelerating its push to reshape MedTech innovation.

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 3.5% Wednesday after the precision medicine technology company announced the launch of its new HRD-RNA algorithm for cancer detection.

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with Genialis, ...

In a recent study published in Scientific Reports, researchers developed a novel algorithm to analyze large genomic datasets of ribonucleic acid (RNA) viruses, applying it to severe acute respiratory ...

So far, it has not been possible to explain the causes of around half of all rare hereditary diseases. A Munich research team has developed an algorithm that predicts the effects of genetic mutations ...

The SARS-CoV-2 pandemic greatly accelerated the development of messenger RNA technology by demonstrating the safety, effectiveness and scalability of mRNA-based vaccines 1. Writing in Nature, Zhang et ...